Assessing 898 COVID-19 Shot Studies: #23 to #33

Discontinued series

Note: This is an old article that I never published earlier due to time constraints. I won’t be continuing the 898 studies (see article “I Stayed Up Until 3 AM To Refute The CDC”). I’m publishing this so the analysis doesn’t go to waste.

If you’re new to this, see our first article in the series: “Assessing 898 COVID-19 Shot Studies: Studies #1 to #11” for context. For our previous article in the series, see: “Assessing 898 COVID-19 Shot Studies: Studies #12 to #22”. We have now removed the extra “Studies” from our title.

23. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

It tries to dilute the issue by mentioning there’s a “backdrop of 2.8 million doses of mRNA COVID-19 vaccines administered”, but this fails to mention along what strata (context suggests military but it’s not stated explicitly which is bad peer review form).

Even if they go ‘look, there are 2.8 million doses’ - remember, most people received two doses. The subtle wordplay of replacing shots with doses means you actually have - not counting third, fourth etc shots - roughly 1.4 million shots.

A minimum of 2 doses are assumed per person because a full course at the time - 2 doses - is required by the US military, and non-takers wouldn’t factor in as they’d have left the military or given full exemption. There may be a possibility they took more doses, but this is the conservative minimum.

That would mean (bearing in mind they are not reporting any other conditions) the 23 cases of myocarditis, out of 1.4 million shots, would be roughly 1 case for every 60,869 shots.

1 out of 60,869 shots fits within other datasets observed (bearing in mind underreporting). According to Yale medicine, they declared:

The side effect is considered important but uncommon—arising in about 12.6 cases per million second doses administered.

Or roughly 1 in every 79,365.

It is worth noting - as the military study does - that military soldiers have to be in peak physical condition:

[…] In this case series of 23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days of receipt of a COVID-19 vaccine. […]

And, reinforcing our prior observations on anaphylaxis, most of the myocarditis are reported to have occurred in the second shot:

For most patients (n = 20), the diagnosis was made after the second dose of mRNA COVID-19 vaccine […]

This would mean in this small study, roughly 86.9% of people get their myocarditis in the second shot. Of which Yale also echoed the adverse impact on males and the second shot issues:

The safety group reports that the majority of cases have occurred in people 30 years old and under, mostly in males, and more often than not, inflammation occurred after the second dose of the vaccine.

24. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

This study finds, for people with ‘acute’ myocarditis (there is no such thing as mild), out of 7 people with it, 4 had received the mRNA shot. It is unclear if the remaining 3 were classified as ‘vaccinated’ and had one of the GM adenovirus shots by AstraZeneca or Johnson&Johnson.

In this study of 7 patients with acute myocarditis, 4 occurred within 5 days of COVID-19 vaccination between February 1 and April 30, 2021. […]

5 days is an extremely short time frame, and although the study tries to bizarrely argue there’s no link of causality, paraphrasing one medical professional who commented, ‘we look at a patient’s back history to see if there were any other possible health concerns or causes; if we don’t find a plausible link to something else, we have to ask ‘what’s changed?’ and usually it is the vaccine’.

4 out of 7 would mean that roughly 57% of those with ‘acute’ myocarditis, received an mRNA shot. The study also interestingly notes there is prior history of shots being associated with myocarditis, namely, smallpox:

Vaccine-associated myocarditis is an unusual entity that has been described for the smallpox vaccine […]

25. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Before we get into this study, it is worth noting the context for children.

In the UK in 2021, there were 8,911,853 registered pupils (18 years and under) [note, this isn’t the total number of children within the UK - only those registered in schools, however accurate child figures are difficult to find]. Between the peak of Mar 2020 to Feb 2021, 25 UK children died from COVID-19, meaning, only 1 out of every 356,474 died.

Remember that 25 number, because it will put into perspective.

BNT162b2 is the BioNTech/Pfizer mRNA shot. The study notes 15 children were hospitalised with myocarditis. That would account for 60% compared to the 25 above.

In this case series of 15 children who were hospitalized with myocarditis after receipt of the BNT162b2 messenger RNA COVID-19 vaccine for 1 to 5 days

It again notes that it most often occurs after the second dose. It also mentions “ventricular systolic dysfunction” (VSD), but fails to specify what classification:

[…] boys were most often affected after the second vaccine dose, 3 patients had ventricular systolic dysfunction, […]

Ventricular Systolic Dysfunction has four classifications, according to the NHS:

1. No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.

2. Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.

3. Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances. Comfortable only at rest.

4. Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients.

Now, ‘hospitalisation’ here isn’t defined. It could mean a normal inpatient appointment, or it could mean the ‘blues-and-twos’ ambulance straight through A&E.

We can however rule out Class I, because it presents no symptoms. I personally would also rule out Class II, because the symptomology is mild enough it would likely be misclassified, misattributed, or not seen as an issue.

Class III is possible, assuming it was an inpatient appointment. However, for the patients to require so many examinations, I’m confident these were mostly Class IV cases.

[…] and 12 patients had late gadolinium enhancement on cardiac magnetic resonance imaging.

The study tries to downplay the fact that all the children here got hospitalised by over-emphasing the fact their echocardiogram (not to be confused with an electrocardiogram) was ‘normal’ after several days:

There was no mortality, and all but 1 patient had normal echocardiogram results on follow-up 1 to 13 days after discharge.

An echocardiogram is an ultrasound of the heart which deals with physical valve movements and potential wall deformities. However, as the above study notes, you typically observe for myocarditis via cardiac magnetic resonance imaging.

It is quite possible the cell wall on a heart could be dead or damaged, but wouldn’t show any easy-to-detect deformities on an ultrasound as an echocardiogram. Which is why cardiac MRI is typically used. So the remark it was ‘normal’ is worthless. It’s like saying grandma’s eyesight is okay because she passed the pupil reflex test. Absurd.

It begs the question why they didn’t repeat the cMRI they had conducted previously to determine recovery. They also didn’t mention what the patient’s actual prognosis was, or whether they had to make life changes (E.G. avoid exertion).

Don’t confuse the lack of fatality with an absence of life changing events. Someone being disabled for life is equally as terrible as someone being killed, as not only does it ruin their quality of life, but costs money to deal with. No problem for pharmaceutical companies who make money selling the ‘cures’ to the illnesses, of course.

26. Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

BNT162b2 is BioNTech’s mRNA shot.

The study is curious because it doesn’t ask if the mRNA shots cause Guillain-Barré Syndrome (GBS), but it very narrowly asks if mRNA shot cause GBS to return. It is mildly bizarre because GBS is, to my knowledge, permanent. Which means it can’t “reoccur” if it never left in the first place. Naturally they conclude the obvious in it doesn’t cause GBS to reoccur.

They’ve already narrowed down their criterion to a very bizarre selection process, and normally you’d skip such a terribly designed study. That said, there is a very useful table.

From 702 prior GBS cases, they had narrowed the list down to 579 referring to single dose, but it is unclear if this also included two doses, and of these 579 they had narrowed the list down to 48 who were hospitalised. Amazingly, they actually bother to document if the hospitalisations were emergency admissions or routine admissions.

Now, for convenience of analysis I had this table transcribed into an Open Document Spreadsheet, which can be opened with free software such as Libre Office (no guarantees on accuracy of transcription), and it reveals some interesting stuff.

24 of the records were emergency department admissions. Of these, the soonest was the same day as the shot (day 0), with a patient experiencing Paresthesia (feeling weird sensations on the skin). 6 cases were within 5 days, 1 of which was a seizure.

Of these, 17 patients had taken the second shot out of the 24, meaning over 70% of patients were admitted after the second shot. Of these, 7 appear to be vascular related, with the worst being Hemolytic Anemia (the destruction of red blood cells) and the least severe being Syncope (fainting, likely due to low blood pressure).

Excluding 7 records of trauma (with unspecified details) and 1 suicide attempt (over being crippled by the shot? Hard to say), there were 16 cases that could be attributable, with an average occurrence period of 25 days.

Although the study says the data does not support warning GBS of issues with the shot in relation to GBS, they seem to have missed the rather large warning flags given even if we lowball and pick a conservative 16 emergency admissions out of the highest 702 cases, it would mean an emergency hospital visit was guaranteed in people with GBS in roughly every 43 shots, which would suggest to the contrary of their study. Oops.

27. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

This shares overlap with the EMA leak documents I previously reported on, which mentioned the transverse sinus thrombosis death for the Janssen shot, which is a genetically modified recominant adenovirus shot (like the AstraZeneca shot):

ChAdOx1 - AstraZeneca shot.

CVST - Cerebral Venous Sinus Thrombosis.

The study notes they covered 116 patients with CVST postvaccination, a majority of which were AstraZeneca, followed by Pfizer, with smaller percents divided between Sinopharm’s Sinovac, Janssen and Moderna’s shots

[…] we included 116 patients with postvaccination CVST, diagnosed between January 30 and June 14, 2021. In total, 96 patients (82.8%) were vaccinated with ChAdOx1 nCov-19, 16 (13.8%) with BNT162b2 (Pfizer/BioNTech), 2 (1.7%) with CoronaVac (Sinovac), 1 (0.9%) with Ad26.COV2.S, and 1 (0.9%) with mRNA-1273 (Moderna)

TTS - Thrombosis With Thrombocytopenia Syndrome.

Besides the fact the study reveals a distinctly alarming trend in CVST from post vaccination, it goes on to note if the patients also had TTS with the postvaccination, it led to more fatal outcomes “high mortality rate”:

In this cohort study of patients with CVST, a distinct clinical profile and high mortality rate was observed in patients meeting criteria for TTS after SARS-CoV-2 vaccination.

28. Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series

A pretty straight-forward case series. Documents how 5 children ended up with acute myocarditis following either Pfizer or Moderna shots. 4 of the cases occurred after the second shot, with 1 after the first. 4 of the cases were Pfizer, only 1 was Moderna.

Remember, only 25 children died from COVID-19 between March 2020 and February 2021.. We’ve already severely injured 5 here with the shots.

29. Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination

(This URL appears to mysteriously time out. It can be alternatively viewed here.)

Another study talking about CVST, all involving AstraZeneca. 4 cases, all women in their 40s. 3 had additional conditions. Medical professionals will want to examine this study particularly, because it goes into extensive depth on bloods, including D-Dimer levels and more, and thus offers a higher resolution of detail than usual.

It is particularly damning in what it shows. So a ‘positive’ (not positive in good, but positive as in verified) D-dimer test is anything >500ng/ml. In all four of these cases, the women has D-dimer levels over 20,000:

A D-dimer, for those not familiar, is a protein fragment that forms after a blood clot dissolves. So a high D-dimer implies a lot of dissolved blood clots. Yikes.

30. Myocarditis Following mRNA COVID-19 Vaccine

Straight forward case study involving an adolescent with tachycardia after receiving the Pfizer shot. It suggests ultrasound might be able to detect function issues:

Point-of-care ultrasound was performed prior to the return of laboratory studies and revealed depressed left ventricular systolic function

If you scroll up, ventricular systolic dysfunction (VSD) was mentioned under study #25, reinforcing this noticeable trend.

31. Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine

In my humble opinion this study is pretty slipshod. Although it confirms that most of the incidences are after the second shot:

In 6 of the 7 patients, symptoms began following the 2nd dose and in 1 patient following the 1st dose. […]

The article tries to, bizarrely, insist “all cases were mild” because “none required cardiovascular or respiratory support”. This is a bizarre logic to argue because there’s no meaningful treatment for myocarditis, so course there will be no support besides ‘stay at home and don’t exert yourself’ type advice.

The study even admits their own shortsightedness and contradicts their own claim by saying actually they can’t be sure unless they do follow up (emphasis added):

All cases were mild, although only long-term follow-up can reveal the true impact of this cardiac injury

Then how are they even able to insist it is mild if they have no follow-up on outcomes? Bizarre.

32. Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine

This study details one case where an individual got GBS after receiving the Pfizer mRNA shot. The study goes into details of the issues experienced by the individual - in more depth than most studies - and suggest their examination for other possible causes coming back negative suggest the Pfizer mRNA shot is responsible:

We believe that the clinical and laboratory findings including the lack of overt trigger are consistent with a causal association between GBS and Pfizer® anti-SARS-CoV-2 vaccine

Despite this, the study, like many studies, is too afraid to criticise the false idol vaccine ‘god’ and goes on to parrot the unevidenced benefits:

[…] even though the individual risk for GBS and other rare complications is likely to be very small, and the benefit of protection against COVID-19 both for individuals and society is far greater

The study goes on to propose that this giant guinea pig experiment be exploited to further study GBS associations with mRNA shots:

[…] it might be essential to exploit the opportunity of a worldwide vaccination campaign, perhaps the largest in history, to better understand the pathogenetic mechanism that bind GBS to COVID vaccination, rather than denying such association.

33. COVID-19 mRNA vaccination leading to CNS inflammation: a case series

CNS - Central Nervous System.

A case study, it discusses 7 patients: 4 who took Pfizer, 3 who took Moderna; of which 5 experienced CNS issues after the second shot. The MRI revealed active CNS demyelination of the optic nerve, brain, and/or spinal cord. Demyelination refers to damage to the myelin (a lipid-rich material that surrounds nerve cell axons; essentially a protective covering for neuron cells) through inflammation.

That is to say, in these cases, damage occurred to the neuron cells as a result of the SARS-CoV-2 shots. As the study notes:

Symptoms included visual loss, dysmetria [issues with accuracy of arm/leg movement], gait instability, paresthesias [abnormal sensation of the skin], sphincter disturbance, and limb weakness.

Meaning they suffered severe neurological impairments as a result of taking the mRNA shots. It is interesting that the lipid parts of neurons are impacted, given that the mRNA delivery is in lipid nanoparticles.

Phew! Analysing this many studies takes a lot of time and work. If you liked, learned something new or used this work, please help keep financing my ability to do in-depth reporting by becoming a paid subscriber!

For our previous article in the series, see: “Assessing 898 COVID-19 Shot Studies: Studies #12 to #22”

Like what you see? Subscribe.

Want to share what you’ve learned with others? Share.

Got feedback?